vs
Side-by-side financial comparison of HARROW, INC. (HROW) and Limbach Holdings, Inc. (LMB). Click either name above to swap in a different company.
Limbach Holdings, Inc. is the larger business by last-quarter revenue ($138.9M vs $89.1M, roughly 1.6× HARROW, INC.). HARROW, INC. runs the higher net margin — 7.4% vs 3.2%, a 4.3% gap on every dollar of revenue. On growth, HARROW, INC. posted the faster year-over-year revenue change (33.3% vs 4.3%). Over the past eight quarters, HARROW, INC.'s revenue compounded faster (60.5% CAGR vs 6.6%).
Harrow Health, Inc., formerly known as Imprimis Pharmaceuticals, is a publicly traded pharmaceutical company based in Nashville, Tennessee.
Limbach Flugmotoren is a Chinese-owned company based in Germany that produces aircraft engines.
HROW vs LMB — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $89.1M | $138.9M |
| Net Profit | $6.6M | $4.4M |
| Gross Margin | 79.3% | 22.4% |
| Operating Margin | 17.5% | 0.8% |
| Net Margin | 7.4% | 3.2% |
| Revenue YoY | 33.3% | 4.3% |
| Net Profit YoY | -2.2% | — |
| EPS (diluted) | $0.20 | $0.36 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $138.9M | ||
| Q4 25 | $89.1M | $186.9M | ||
| Q3 25 | $71.6M | $184.6M | ||
| Q2 25 | $63.7M | $142.2M | ||
| Q1 25 | $47.8M | $133.1M | ||
| Q4 24 | $66.8M | $143.7M | ||
| Q3 24 | $49.3M | $133.9M | ||
| Q2 24 | $48.9M | $122.2M |
| Q1 26 | — | $4.4M | ||
| Q4 25 | $6.6M | $12.3M | ||
| Q3 25 | $1.0M | $8.8M | ||
| Q2 25 | $5.0M | $7.8M | ||
| Q1 25 | $-17.8M | $10.2M | ||
| Q4 24 | $6.8M | $9.8M | ||
| Q3 24 | $-4.2M | $7.5M | ||
| Q2 24 | $-6.5M | $6.0M |
| Q1 26 | — | 22.4% | ||
| Q4 25 | 79.3% | 25.7% | ||
| Q3 25 | 75.3% | 24.2% | ||
| Q2 25 | 74.5% | 28.0% | ||
| Q1 25 | 67.5% | 27.6% | ||
| Q4 24 | 78.8% | 30.3% | ||
| Q3 24 | 75.6% | 27.0% | ||
| Q2 24 | 74.4% | 27.4% |
| Q1 26 | — | 0.8% | ||
| Q4 25 | 17.5% | 9.4% | ||
| Q3 25 | 20.6% | 7.2% | ||
| Q2 25 | 17.9% | 7.5% | ||
| Q1 25 | -23.5% | 5.9% | ||
| Q4 24 | 19.3% | 9.1% | ||
| Q3 24 | 2.7% | 8.1% | ||
| Q2 24 | 3.1% | 6.7% |
| Q1 26 | — | 3.2% | ||
| Q4 25 | 7.4% | 6.6% | ||
| Q3 25 | 1.4% | 4.8% | ||
| Q2 25 | 7.8% | 5.5% | ||
| Q1 25 | -37.2% | 7.7% | ||
| Q4 24 | 10.1% | 6.9% | ||
| Q3 24 | -8.6% | 5.6% | ||
| Q2 24 | -13.2% | 4.9% |
| Q1 26 | — | $0.36 | ||
| Q4 25 | $0.20 | $1.01 | ||
| Q3 25 | $0.03 | $0.73 | ||
| Q2 25 | $0.13 | $0.64 | ||
| Q1 25 | $-0.50 | $0.85 | ||
| Q4 24 | $0.19 | $0.81 | ||
| Q3 24 | $-0.12 | $0.62 | ||
| Q2 24 | $-0.18 | $0.50 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $72.9M | $15.8M |
| Total DebtLower is stronger | $250.0M | $56.6M |
| Stockholders' EquityBook value | $52.4M | $196.3M |
| Total Assets | $399.5M | $377.0M |
| Debt / EquityLower = less leverage | 4.77× | 0.29× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $15.8M | ||
| Q4 25 | $72.9M | $11.3M | ||
| Q3 25 | $74.3M | $9.8M | ||
| Q2 25 | $53.0M | $38.9M | ||
| Q1 25 | $66.7M | $38.1M | ||
| Q4 24 | $47.2M | $44.9M | ||
| Q3 24 | $72.6M | $51.2M | ||
| Q2 24 | $71.0M | $59.5M |
| Q1 26 | — | $56.6M | ||
| Q4 25 | $250.0M | $30.5M | ||
| Q3 25 | $347.2M | $56.3M | ||
| Q2 25 | $250.6M | $28.4M | ||
| Q1 25 | $256.9M | $23.7M | ||
| Q4 24 | $262.7M | $23.6M | ||
| Q3 24 | $230.7M | $20.5M | ||
| Q2 24 | $236.3M | $19.7M |
| Q1 26 | — | $196.3M | ||
| Q4 25 | $52.4M | $195.7M | ||
| Q3 25 | $47.0M | $181.6M | ||
| Q2 25 | $49.7M | $170.5M | ||
| Q1 25 | $56.5M | $161.1M | ||
| Q4 24 | $69.7M | $153.5M | ||
| Q3 24 | $58.0M | $142.2M | ||
| Q2 24 | $58.5M | $133.0M |
| Q1 26 | — | $377.0M | ||
| Q4 25 | $399.5M | $381.1M | ||
| Q3 25 | $363.1M | $409.1M | ||
| Q2 25 | $345.0M | $343.0M | ||
| Q1 25 | $364.2M | $336.4M | ||
| Q4 24 | $389.0M | $352.1M | ||
| Q3 24 | $351.5M | $324.4M | ||
| Q2 24 | $306.6M | $303.9M |
| Q1 26 | — | 0.29× | ||
| Q4 25 | 4.77× | 0.16× | ||
| Q3 25 | 7.39× | 0.31× | ||
| Q2 25 | 5.05× | 0.17× | ||
| Q1 25 | 4.55× | 0.15× | ||
| Q4 24 | 3.77× | 0.15× | ||
| Q3 24 | 3.98× | 0.14× | ||
| Q2 24 | 4.04× | 0.15× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $8.4M | — |
| Free Cash FlowOCF − Capex | $8.1M | — |
| FCF MarginFCF / Revenue | 9.1% | — |
| Capex IntensityCapex / Revenue | 0.4% | — |
| Cash ConversionOCF / Net Profit | 1.27× | — |
| TTM Free Cash FlowTrailing 4 quarters | $43.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $8.4M | $28.1M | ||
| Q3 25 | $16.6M | $13.3M | ||
| Q2 25 | $-803.0K | $2.0M | ||
| Q1 25 | $19.7M | $2.2M | ||
| Q4 24 | $-17.8M | $19.3M | ||
| Q3 24 | $3.0M | $4.9M | ||
| Q2 24 | $-2.7M | $16.5M |
| Q1 26 | — | — | ||
| Q4 25 | $8.1M | $27.9M | ||
| Q3 25 | $16.4M | $12.8M | ||
| Q2 25 | $-969.0K | $1.2M | ||
| Q1 25 | $19.5M | $11.0K | ||
| Q4 24 | $-18.3M | $18.0M | ||
| Q3 24 | $2.3M | $4.6M | ||
| Q2 24 | $-3.1M | $13.2M |
| Q1 26 | — | — | ||
| Q4 25 | 9.1% | 14.9% | ||
| Q3 25 | 22.9% | 7.0% | ||
| Q2 25 | -1.5% | 0.8% | ||
| Q1 25 | 40.8% | 0.0% | ||
| Q4 24 | -27.4% | 12.5% | ||
| Q3 24 | 4.8% | 3.4% | ||
| Q2 24 | -6.3% | 10.8% |
| Q1 26 | — | — | ||
| Q4 25 | 0.4% | 0.1% | ||
| Q3 25 | 0.3% | 0.3% | ||
| Q2 25 | 0.3% | 0.6% | ||
| Q1 25 | 0.4% | 1.7% | ||
| Q4 24 | 0.8% | 0.9% | ||
| Q3 24 | 1.2% | 0.3% | ||
| Q2 24 | 0.7% | 2.7% |
| Q1 26 | — | — | ||
| Q4 25 | 1.27× | 2.29× | ||
| Q3 25 | 16.26× | 1.52× | ||
| Q2 25 | -0.16× | 0.26× | ||
| Q1 25 | — | 0.22× | ||
| Q4 24 | -2.62× | 1.96× | ||
| Q3 24 | — | 0.66× | ||
| Q2 24 | — | 2.77× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HROW
Segment breakdown not available.
LMB
| ODR | $99.8M | 72% |
| GCR | $39.0M | 28% |
